<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="68645">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01685840</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00033097</org_study_id>
    <nct_id>NCT01685840</nct_id>
  </id_info>
  <brief_title>Guiding Evidence Based Therapy Using Biomarker Intensified Treatment</brief_title>
  <acronym>GUIDE-IT</acronym>
  <official_title>Guiding Evidence Based Therapy Using Biomarker Intensified Treatment in Heart Failure.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Duke University</source>
  <oversight_info>
    <authority>United States: Federal Government</authority>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective is to determine the efficacy of a strategy of biomarker-guided therapy
      compared with usual care in high risk patients with left ventricular systolic dysfunction.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Heart failure is a common disorder in which the heart cannot pump enough blood to meet the
      needs of the rest of the body. Common symptoms of heart failure include shortness of breath,
      swelling, and fatigue. Standard treatment for heart failure include diuretics to control
      fluid, as well as drugs called &quot;neurohormonal antagonists&quot; (such as beta-blockers and
      ACE-inhibitors) that help the heart work more efficiently and prevent worsening of heart
      function. Typically, doctors adjust these medicines based on their clinical judgment about
      what doses and combination will work best for you.  We are testing whether the use of a
      blood test called NT-proBNP (which measures a hormone released by the heart) can help
      doctors do a better job of adjusting these heart failure medicines over time than clinical
      judgment alone.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">September 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Time to CV death or HF Hospitalization</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Time to CV death or first HF hospitalization</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to All-cause mortality</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Time to death</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cumulative Morbidity</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Time alive and not hospitalized for CV reasons</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to Death</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Time to CV death</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first HF hospitalization</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Time to first HF hospitalization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health Related Quality of Life</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Health related quality of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Resource Utilization, cost and cost effectiveness</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>medical costs, resource and cost effectiveness</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with AEs of interest and/ or SAEs</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Number of participants with Adverse Events of interest and/ or Serious Adverse Events.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1100</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>Usual Care</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Usual Care group will receive standard heart failure treatment based on the doctor's best judgment and following the recommendation of current guidelines. This will typically include the use of medicines such as beta-blockers, ACE-inhibitors, and diuretics, all of which are approved, recommended treatments for heart failure.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Biomarker-Guided Care</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Device: Biomarker-Guided care NT-proBNP The Biomarker Guided Therapy  group will receive the standard heart failure treatments. In addition, the doctor will use the results of a blood test called NT-proBNP to help adjust the treatments and drug doses.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Usual Care</intervention_name>
    <description>Usual Care</description>
    <arm_group_label>Usual Care</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Biomarker-guided care NT-proBNP</intervention_name>
    <description>Device: NT-proBNP</description>
    <arm_group_label>Biomarker-Guided Care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18 years or older

          -  Hospitalization for acute decompensated HF, manifest by Dyspnea at rest or on minimal
             exertion plus At least 1 sign of volume overload:

          -  Elevated jugular venous pulse

          -  Pulmonary rates

          -  Peripheral edema

          -  Congestion on chest x-ray

          -  Most recent documented LVEF to be â‰¤ 40% by any method within 12 months of
             randomization. This assessment must occur at least 12 weeks after any intervention
             likely to improve ejection fraction (e.g., cardiac resynchronization therapy,
             initiation of beta-blocker therapy, or revascularization).

          -  NT-ProBNP &gt; 2000 pg/mL at least once during index hospitalization

          -  Willing to provide informed consent

        Exclusion Criteria:

          -  Acute coronary syndrome (clinical diagnosis) or cardiac revascularization procedure
             within 30 days

          -  Cardiac resynchronization therapy (CRT) within prior 3 months or current plan to
             implant CRT device

          -  Active myocarditis, Hypertrophic obstructive cardiomyopathy, pericarditis, or
             restrictive cardiomyopathy

          -  Severe stenotic valvular disease

          -  Anticipated heart transplantation or ventricular assist device within 12 months

          -  Chronic inotropic therapy

          -  Complex congenital heart disease

          -  End stage renal disease with renal replacement therapy

          -  Non cardiac terminal illness with expected survival less than 12 months

          -  Women who are pregnant or planning to become pregnant

          -  Inability to comply with planned study procedures

          -  Enrollment or planned enrollment in another clinical trial
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Felker, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gayle Paynter, RN, MBA</last_name>
    <phone>919-668-8641</phone>
    <email>gayle.e.paynter@duke.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>The Heart Center PC</name>
      <address>
        <city>Huntsville</city>
        <state>Alabama</state>
        <zip>35801</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>James Murphy, MD</last_name>
      <phone>256-519-8472</phone>
      <email>jmurphy@theheartcenter.md</email>
    </contact>
    <investigator>
      <last_name>James Murphy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sutter Memorial Hospital</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95819</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Chin, MD</last_name>
      <phone>916-733-7102</phone>
      <email>jchin@rcamd.com</email>
    </contact>
    <investigator>
      <last_name>John Chin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California San Diego Medical Center</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92037</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Barry Greenberg, MD</last_name>
      <email>bgreenberg@ucsd.edu</email>
    </contact>
    <investigator>
      <last_name>Barry Greenberg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Holy Cross Medical Group</name>
      <address>
        <city>Coral Springs</city>
        <state>Florida</state>
        <zip>33065</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ricky Schneider, MD</last_name>
      <phone>954-346-0864</phone>
      <email>rmschneid@ymail.com</email>
    </contact>
    <investigator>
      <last_name>Ricky Schneider, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Flordia</name>
      <address>
        <city>Gainsville</city>
        <state>Florida</state>
        <zip>32610</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juan Aranda, MD</last_name>
      <phone>352-265-0751</phone>
      <email>arandjm@medicine.ufl.edu</email>
    </contact>
    <investigator>
      <last_name>Juan Aranda, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fox Valley Clinical Research Center, LLC</name>
      <address>
        <city>Aurora</city>
        <state>Illinois</state>
        <zip>60504</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Santosh Gill, MD</last_name>
      <phone>603-723-3485</phone>
      <email>research@foxvalleyresearch.com</email>
    </contact>
    <investigator>
      <last_name>Santosh Gill, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Maryland</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gautam Ramani, MD</last_name>
      <email>gramani@medicine.umaryland.edu</email>
    </contact>
    <investigator>
      <last_name>Gautam Ramani, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Metropolitan Cardiovascular Consultants</name>
      <address>
        <city>Beltsville</city>
        <state>Maryland</state>
        <zip>20705</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ayim Akyea-Djamson, MD</last_name>
      <phone>202-904-8599</phone>
      <email>adjamson@metresearch.org</email>
    </contact>
    <investigator>
      <last_name>Ayim Akyea-Djamason, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Beth Israel Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Kociol, MD</last_name>
      <phone>617-667-8800</phone>
      <email>rkociol@bidmc.harvard.edu</email>
    </contact>
    <investigator>
      <last_name>Robert Kociol, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>James Januzzi, MD</last_name>
      <phone>617-726-3443</phone>
      <email>jjanuzzi@partners.org</email>
    </contact>
    <investigator>
      <last_name>James Januzzi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wayner Miller, MD</last_name>
      <phone>507-284-3685</phone>
      <email>miller.wayne@mayo.edu</email>
    </contact>
    <investigator>
      <last_name>Wayner Miller, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Washington University School of Medicine</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gregory Ewald, MD</last_name>
      <phone>314-454-7009</phone>
      <email>gewald@dom.wustl.edu</email>
    </contact>
    <investigator>
      <last_name>Gregory Ewald, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dartmouth Hitchcock Medical Center</name>
      <address>
        <city>Lebanon</city>
        <state>New Hampshire</state>
        <zip>03756</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alan Kono, MD</last_name>
      <phone>603-650-5650</phone>
      <email>alan.t.kono@hitchcock.org</email>
    </contact>
    <investigator>
      <last_name>Alan Kono, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cardiovascular Associates of the Delaware Valley</name>
      <address>
        <city>Cherry Hill</city>
        <state>New Jersey</state>
        <zip>08034</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>856-358-8125</phone>
      <email>mgelernt@comcast.net</email>
    </contact>
    <investigator>
      <last_name>Mark Gelernt, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Robert Wood Johnson University Hospital</name>
      <address>
        <city>New Brunswick</city>
        <state>New Jersey</state>
        <zip>08903</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Kostis, MD</last_name>
      <phone>732-235-6546</phone>
      <email>kostis@rwjms.rutgers.edu</email>
    </contact>
    <investigator>
      <last_name>John Kostis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cardiovascular Associates of the Delaware Valley</name>
      <address>
        <city>Sewell</city>
        <state>New Jersey</state>
        <zip>08080</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>717-441-1725</phone>
      <email>dilip.viswanath@comcast.net</email>
    </contact>
    <investigator>
      <last_name>Dilip Viswanath, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Jacobi Medical Center</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10461</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Siegel, MD</last_name>
      <phone>718-918-5904</phone>
      <email>robert.siegel@nbhn.net</email>
    </contact>
    <investigator>
      <last_name>Robert Siegel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Albert Einstein University Hospital</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10467</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ileana Pina, MD</last_name>
      <phone>718-920-4176</phone>
      <email>ilppina@aol.com</email>
    </contact>
    <investigator>
      <last_name>Ileana Pina, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bronx-Lebanon Hospital Center</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10457</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sherry Megalla, MD</last_name>
      <phone>718-518-5222</phone>
      <email>smegalla@bronxleb.org</email>
    </contact>
    <investigator>
      <last_name>Sherry Megella, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>New York Methodist Hospital</name>
      <address>
        <city>Brooklyn</city>
        <state>New York</state>
        <zip>11215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>718-780-5037</phone>
      <email>jfh9003@nyp.org</email>
    </contact>
    <investigator>
      <last_name>John Heitner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Saratoga Cardiology Associates</name>
      <address>
        <city>Saratoga Springs</city>
        <state>New York</state>
        <zip>12866</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roland Phillips, MD</last_name>
      <phone>518-693-0187</phone>
      <email>rphillips@saracard.com</email>
    </contact>
    <investigator>
      <last_name>Roland Phillips, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of North Carolina at Chapel Hill</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27599</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kirkwood Adams, MD</last_name>
      <phone>919-843-5223</phone>
      <email>kfa@med.unc.edu</email>
    </contact>
    <investigator>
      <last_name>Kirkwood Adams, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Novant Health Heart and Vascular Institute</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28204</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edwards McMillan, MD</last_name>
      <phone>704-264-1400</phone>
      <email>ebmcmillan@novanthealth.org</email>
    </contact>
    <investigator>
      <last_name>Edwards McMillan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chetan Patel, MD</last_name>
      <phone>919-668-8955</phone>
      <email>chetan.patel@duke.edu</email>
    </contact>
    <investigator>
      <last_name>Chetan Patel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>LeBauer Cardiovascular Research Foundation</name>
      <address>
        <city>Greensboro</city>
        <state>North Carolina</state>
        <zip>27401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>336-547-1751</phone>
      <email>d.bensimhon@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Daniel Bensimhon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Cincinnati Medical Center</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45267</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephanie Dunlap, MD</last_name>
      <email>stephanie.dunlap@uc.edu</email>
    </contact>
    <investigator>
      <last_name>Stephanie Dunlap, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic Foundation</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>wilson Tang, MD</last_name>
      <phone>216-444-2121</phone>
      <email>tangw@ccf.org</email>
    </contact>
    <investigator>
      <last_name>Wilson Tang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Capitol Area Research, LLC</name>
      <address>
        <city>Camp Hill</city>
        <state>Pennsylvania</state>
        <zip>17011</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>717-441-1725</phone>
      <email>vnadar@care-research.com</email>
    </contact>
    <investigator>
      <last_name>Venkatesh Nadar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Drexel University College of Medicine</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19102</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Howard Eisen, MD</last_name>
      <phone>215-762-3829</phone>
      <email>heisen@drexelmed.edu</email>
    </contact>
    <investigator>
      <last_name>Howard Eisen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Thomas Jefferson University Hospital</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raphael Bonita, MD</last_name>
      <phone>215-955-5050</phone>
      <email>raphael.bonita@jefferson.edu</email>
    </contact>
    <investigator>
      <last_name>Raphael Bonita, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Pennsylvania Health System</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lee Goldberg, MD</last_name>
      <phone>215-615-0820</phone>
      <email>lee.goldberg@uphs.upenn.edu</email>
    </contact>
    <investigator>
      <last_name>Lee Goldberg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AnMed Health Medical Center</name>
      <address>
        <city>Anderson</city>
        <state>South Carolina</state>
        <zip>29621</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Harold Morse, MD</last_name>
      <phone>864-261-1800</phone>
      <email>harold.morse@anmedhealth.org</email>
    </contact>
    <investigator>
      <last_name>Harold Morse, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Texas Southwestern Medical Center Dallas</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mark Drazner, MD</last_name>
      <phone>214-645-7500</phone>
      <email>mark.drazner@utsouthwestern.edu</email>
    </contact>
    <investigator>
      <last_name>Mark Drazner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Intermountain Medical Center</name>
      <address>
        <city>Murry</city>
        <state>Utah</state>
        <zip>84157</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Deborah Budge, MD</last_name>
      <phone>801-507-4000</phone>
      <email>deborah.budge@imail.org</email>
    </contact>
    <investigator>
      <last_name>Deborah Budge, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cardiovascular Associates, Ltd.</name>
      <address>
        <city>Chesapeake</city>
        <state>Virginia</state>
        <zip>23320</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>757-547-9294</phone>
      <email>wold@cval.org</email>
    </contact>
    <investigator>
      <last_name>Wayne Old, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Foothills Medical Centre</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T2N 4Z6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patricia Campbell, MD</last_name>
      <phone>1-403-220-8282</phone>
      <email>patricia.m.campbell@albertahealthservices.ca</email>
    </contact>
    <investigator>
      <last_name>Patricia Campbell, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Alberta Hospital</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <zip>T6G 2B7</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Justin Ezekowitz, MD</last_name>
      <phone>1-780-407-8822</phone>
      <email>jae2@ualberta.ca</email>
    </contact>
    <investigator>
      <last_name>Justin Ezekowitz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Saint Paul's Hospital</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V6Z 1Y6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mustafa Toma, MD</last_name>
      <email>mtoma@providencehealth.bc.ca</email>
    </contact>
    <investigator>
      <last_name>Mustafa Toma, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vancouver General Hospital</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V5Z 1M9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sean Virani, MD</last_name>
      <email>svirani@telus.net</email>
    </contact>
    <investigator>
      <last_name>Sean Virani, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hamilton Health Sciences</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8L 2X2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert McKelvie, MD</last_name>
    </contact>
    <investigator>
      <last_name>Robert McKelvie, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Michaels Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5B 1W8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Gordon Moe, MD</last_name>
    </contact>
    <investigator>
      <last_name>Gordon Moe, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
    <country>Canada</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>October 16, 2013</lastchanged_date>
  <firstreceived_date>September 12, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Heart Failure</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
